Gedeon Richter plc announced that it has entered into a distribution and supply agreement with Allergan plc to commercialize its levonorgestrel releasing Intrauterine System (IUS) in Western Europe and in other European countries under the trademark of Levosert®. National marketing authorizations have been already granted in Western and Northern Europe and the product has been launched by Allergan in a number of these countries. The product is already marketed by Richter in most of the Central and Eastern European countries according to an agreement established with Uteron Pharma in 2011.

Under the terms of the agreement Richter shall make an upfront payment upon signature of the contract. In addition, further sales related royalties and milestone payments will become payable to Allergan subsequent to the launch of the product.